Classification of complaints related to AF (EHRA scale)

mEHRA score	Symptoms/Description
1	No symptoms
2а	Mild symptoms – normal daily activity non affected, symptoms not troublesome to patient
2б	Moderate symptoms – normal daily activity non affected, but patient troubled by symptoms
3	Severe symptoms – normal daily activity affected
4	Disabling symptoms – normal daily activity discontinued

Register on our website right now to have access to more learning materials!

Multiple Myeloma Diagnostic Criteria – Online Calculator

February 5, 2023

Email (indicate if you want the results to be sent to your email)

Date of assessment

≥1 of the following (A or B)

A. Clonal bone marrow plasma cells ≥10%

B. Biopsy-proven bony or extramedullary plasmacytoma

≥1 myeloma defining event (C1 or C2)

• C1. End organ damage attributable to underlying plasma cell disorder (≥1 of the following): *

o Hypercalcemia (Serum calcium >1 mg/dL (>0.25 mmol/L) higher than upper limit of normal or >11 mg/dL (>2.75 mmol/L))

o Renal insufficiency (Creatinine clearance<40 mL per min or serum creatinine >2 mg/dL (177 μmol/L))

o Anemia (Hemoglobin >2 g/dL (20 g/L) below lower limit of normal

o Bone lesions (≥1 osteolytic lesion on skeletal x-ray

• C2. ≥1 of the following biomarkers of malignancy: *

o Clonal bone marrow plasma cells ≥60%

o Involved:uninvolved sFLC ratio ≥100

o >1 focal lesion on MRI

Result

Diagnostic result

Negative. Not positive for multiple myeloma by IMWG criteria

Diagnostic result

Positive for multiple myeloma by IMWG criteria

Details:

* Required

For Multiple Myeloma Diagnostic Criteria assessment necessary to provide selection of the…

Revised Multiple Myeloma International Staging System (R-ISS) Online Calculator

January 17, 2023

Revised Multiple Myeloma International Staging System (R-ISS) – prognostication tool for myeloma patients based on…

Multiple Myeloma International Staging System (ISS) Online Calculator

January 16, 2023

Multiple Myeloma International Staging System (ISS) prognosticates the severity of multiple myeloma based on routinely…

SAVED VTE Score

January 11, 2023

SAVED score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulators. [ezfc…

IMPEDE VTE Score

January 11, 2023

IMPEDE score for venous thromboembolism risk stratification in patients with multiple myeloma receiving immunomodulators. [ezfc…

Checklist – Counseling “Explain a bone marrow aspiration”

December 4, 2022

IntroductionPointsIntroduces and identifies patient1Gains consent1Explore Checks patients understanding for reason for Bone Marrow Aspiration2Check’s patients understanding…

≥1 of the following (A or B)

≥1 myeloma defining event (C1 or C2)

Related Articles

Register and get a gift!

User registration